Nicotinic Receptor Alpha 7 Protein is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
Overview
...
Nicotinic Receptor Alpha 7 Protein
Introduction
Nicotinic Receptor Alpha 7 Protein is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
The CHRNA7 protein forms a homomeric pentameric ligand-gated ion channel. Each subunit contains an extracellular N-terminal domain with the characteristic Cys-loop motif, followed by four transmembrane domains (TM1-TM4). The channel pore is formed by the TM2 helices, which line the ion conduction pathway. Each subunit has a molecular weight of approximately 56 kDa. The receptor contains binding sites for acetylcholine and nicotine at the interfaces between subunits. The receptor has high permeability to calcium ions (PCa/PNa ~ 6-10), making it particularly important for calcium-dependent signaling.
Normal Function
The α7 nicotinic acetylcholine receptor (nAChR) is a ligand-gated ion channel that rapidly conducts Na+, K+, and most importantly Ca2+ ions upon acetylcholine or nicotine binding. Key functions include:
Fast excitatory neurotransmission in the central nervous system
Modulation of neurotransmitter release (dopamine, glutamate, GABA, acetylcholine)
Regulation of neuronal excitability and synaptic plasticity
Involvement in attention, learning, and memory processes
Immune system modulation through macrophage and microglial expression
Expression Pattern
α7 nAChR expression in the brain and immune system:
[Hippocampus](/brain-regions/hippocampus): High expression in CA1-CA3 pyramidal [neurons](/entities/neurons) and interneurons
[Cortex](/brain-regions/cortex): Wide expression across layers, particularly layer VI
Basal Forebrain: Expression in cholinergic neurons
Thalamus: Moderate expression in relay nuclei
[Microglia](/entities/microglia): Functional expression for neuroimmune modulation
Lymphocytes: Immune cell expression for inflammatory regulation
Role in Neurodegeneration
CHRNA7 is critically implicated in neurodegenerative diseases:
Alzheimer's Disease
Loss of α7 nAChRs correlates with cognitive decline
Aβ1-42 directly binds to α7 receptors, disrupting function
Protects against excitotoxicity and oxidative stress
The study of Nicotinic Receptor Alpha 7 Protein has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
References
[Albuquerque EX, et al, (2009) (2009)](https://pubmed.ncbi.nlm.nih.gov/19303438/)
[Unknown, Levin ED (2013). α7-nicotinic receptors and cognition (2013)](https://pubmed.ncbi.nlm.nih.gov/23029589/)
[Liu Q, et al, (2012) (2012)](https://pubmed.ncbi.nlm.nih.gov/22494433/)
[Unknown, Changeux JP (2012). The nicotinic acetylcholine receptor (2012)](https://pubmed.ncbi.nlm.nih.gov/21048584/)